Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.40 |
| ▸ | NPY1R | P25929 | 5/20 | 0.40 |
| ▸ | NPY2R | P49146 | 4/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.37 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL7443956 | 0.94 | NPY4R (0.40) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL7306618 | 0.88 | PTGS1 (0.43) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL20783903 | 0.87 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL30186441 | 0.87 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL17347853 | 0.87 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL9440021 | 0.87 | NOD1 (0.43) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL18132953 | 0.87 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RKEAP1 | |
| SCHEMBL19139 | 0.87 | NOD1 (0.43) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL19138 | 0.87 | NOD1 (0.43) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL19629051 | 0.87 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0577775-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. | RHONE POULENC RORER INT (US) | 1995-01-11 | — | — | EP | disclosed |
| US-5332726-A | Anticoagulant | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1994-07-26 | — | — | US | disclosed |
| EP-0577775-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1994-01-12 | — | — | EP | disclosed |
| WO-1992017196-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-10-15 | — | — | WO | disclosed |
| EP-0494248-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | — | 1992-08-26 | — | — | EP | disclosed |
| EP-0494248-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-07-15 | — | — | EP | disclosed |
| WO-1991004746-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1991-04-18 | — | — | WO | disclosed |
| US-4952562-A | TREATMENT OF CARDIOVASCULAR DISORDERS | RORER PHARMACEUTICAL CORPORATION (US) | 1990-08-28 | — | — | US | disclosed |